SLC9A1 and myocardial infarction: The activation of NHE1 has been convincingly demonstrated to regulate cardiomyocyte apoptosis and to be deleterious in a number of pathophysiological conditions, including left ventricular hypertrophy, congestive heart failure and myocardial infarction [35, 36].